Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.61 USD | -0.46% | -4.33% | +42.31% |
06-06 | Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024 | |
06-06 | Addex Therapeutics' Q1 Net Loss Widens; Revenue Down | MT |
Business Summary
Number of employees: 23
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Small-molecule Pharmaceutical Products
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +13.99% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +13.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 31/12/01 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 31/05/17 |
Vincent Lawton
CHM | Chairman | 75 | 15/04/09 |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 27/11/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 53 | 31/05/18 |
Tim Dyer
FOU | Founder | 56 | 31/12/01 |
Vincent Lawton
CHM | Chairman | 75 | 15/04/09 |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 27/11/16 |
Isaac Manke
BRD | Director/Board Member | 47 | 31/12/17 |
Ray Hill
BRD | Director/Board Member | 79 | 30/04/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 184,354,496 | 91,486,750 ( 49.63 %) | 86,047,246 ( 46.67 %) | 49.63 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ADDEX THERAPEUTICS LTD 23.93% | 44,113,438 | 23.93% | 3,501,284 $ |
Company contact information
Addex Therapeutics Ltd.
9, Chemin des Mines Plan-les-Ouates
1202, Geneva
+41 22 884 1555
http://www.addextherapeutics.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- ADXN Stock
- ADXN Stock
- Company Addex Therapeutics Ltd